J
Jonathan E. Kaplan
Researcher at Centers for Disease Control and Prevention
Publications - 186
Citations - 22588
Jonathan E. Kaplan is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Population. The author has an hindex of 63, co-authored 186 publications receiving 22039 citations. Previous affiliations of Jonathan E. Kaplan include St. Boniface General Hospital & University of Colorado Denver.
Papers
More filters
Journal ArticleDOI
Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents
Anthony S. Fauci,John G. Bartlett,Eric P. Goosby,M. D. Smith,H. J. Kaiser,S. W. Chang,James M. Anderson,R. Armstead,A. C. Baker,David A Barr,Samuel A. Bozzette,S. Cox,M. Delaney,Fred M. Gordin,W. Greaves,M. Harrington,J. J. Henning,Martin S. Hirsch,J. Jacobs,Richard Marlink,C. Maxwell,J. W. Mellors,D. B. Nash,S. Perryman,Robert T. Schooley,R. Sherer,Stephen A. Spector,G. Torres,Paul A. Volberding,B. A. Brady,E. M. Daniels,D. Feigal,Mark B. Feinberg,H. D. Gayle,T. R. Graydon,Jonathan E. Kaplan,Abe M. Macher,R. F. Martin,Henry Masur,Lynne M. Mofenson,J. Murray,J. O'Neill,L. C. Perez,R. Riseberg,S. Shekar,Sharilyn K. Stanley,J. Whitescarver +46 more
TL;DR: These Guidelines were developed by the Panel* on Clinical Practices for Treatment of HIV Infection convened by the Department of Health and Human Services and the Henry J. Kaiser Family Foundation.
Journal ArticleDOI
Chronic Fatigue Syndrome: A Working Case Definition
Gary P. Holmes,Jonathan E. Kaplan,Nelson M. Gantz,Anthony L. Komaroff,Lawrence B. Schonberger,Sharon E. Straus,James F. Jones,Richard E. Dubois,Charlotte Cunningham-Rundles,Savita Pahwa,Giovanna Tosato,Leonard S. Zegans,David T. Purtilo,Nathaniel A. Brown,Robert T. Schooley,Irena Brus +15 more
TL;DR: A new name is proposed for the chronic Epstein-Barr virus syndrome--the chronic fatigue syndrome--that more accurately describes this symptom complex as a syndrome of unknown cause characterized primarily by chronic fatigue.
DatasetDOI
Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.
TL;DR: The most recent version of the guidelines for the prevention and treatment of opportunistic infections (OI) in HIV-infected adults and adolescents was published in 2002 and 2004, respectively as mentioned in this paper.
Journal ArticleDOI
Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.
Jonathan E. Kaplan,Debra L. Hanson,Mark S. Dworkin,Toni Frederick,Jeanne Bertolli,Mary Lou Lindegren,Scott D. Holmberg,Jeffrey L. Jones +7 more
TL;DR: The incidence of nearly all AIDS-defining opportunistic infections (OIs) decreased significantly in the United States during 1992-1998; decreases in the most common OIs were more pronounced in 1996-1998, during which time highly active antiretroviral therapy (HAART) was introduced into medical care.
Journal ArticleDOI
Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Judith A. Aberg,Jonathan E. Kaplan,Howard Libman,Patricia Emmanuel,Jean Anderson,Valerie E. Stone,James M. Oleske,Judith S. Currier,Joel E. Gallant +8 more
TL;DR: These updated guidelines replace those published in 2004 and are intended for use by health care providers who care for HIV-infected patients or patients who may be at risk for acquiring HIV infection.